Clinical Trials at Florida Cancer Specialists
As of August 2026, 42 paid clinical trials are recruiting at Florida Cancer Specialists, located at 600 N CATTLEMEN RD, SUITE #200, SARASOTA, FL 34232-6422, phone (941) 377-9993 in Sarasota, Florida. Active studies at this site cover conditions such as Advanced Solid Tumor, Endometrial Cancer and Ovarian Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
42 clinical trials at Florida Cancer Specialists
·Clear filters·Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
QTX3034 in Patients With KRAS G12D Mutation
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Study of AVZO-021 in Patients With Advanced Solid Tumors
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
Common conditions studied in Sarasota
- Advanced Solid Tumor (12 active studies)
- Endometrial Cancer (10 active studies)
- Ovarian Cancer (8 active studies)
- Colorectal Cancer (6 active studies)
- Pancreatic Ductal Adenocarcinoma (6 active studies)
- Triple Negative Breast Cancer (6 active studies)
Leading research sponsors in Sarasota
- Janssen Research & Development, LLC
- Sarasota Memorial Health Care System
- Daiichi Sankyo
- Eli Lilly and Company
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Sarasota?
There are approximately 189 recruiting clinical trials in Sarasota, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Sarasota pay participants?
Most recruiting trials in Sarasota compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Sarasota?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Sarasota?
The most common conditions under active study in Sarasota include Advanced Solid Tumor (12), Endometrial Cancer (10), Ovarian Cancer (8), Colorectal Cancer (6), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Sarasota?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Sarasota on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Sarasota?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Sarasota?
Recruiting research sites in Sarasota include Florida Cancer Specialists, Sarasota Memorial Hospital, Sarasota Memorial Health Care System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Sarasota right now?
The largest active categories in Sarasota are Cancer & tumors (75), Cardiovascular (16), Diabetes & metabolic (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Florida Cancer Specialists?
Florida Cancer Specialists is located at 600 N CATTLEMEN RD, SUITE #200, SARASOTA, FL 34232-6422. Use the Google Maps link in the intro above to get directions.
How do I contact Florida Cancer Specialists?
You can reach Florida Cancer Specialists by phone at (941) 377-9993. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.